Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease

The aim of this study is to analyze the segregation of the 102T/C polymorphism in the serotonin 2A receptor gene in patients affected by sporadic and familial Alzheimer's disease (FAD) with and without psychotic symptoms. The polymorphism was analyzed in 275 subjects. A semistructured interview...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biological psychiatry (1969) 2001-09, Vol.50 (6), p.472-475
Hauptverfasser: Nacmias, B, Tedde, A, Forleo, P, Piacentini, S, Guarnieri, B M, Bartoli, A, Ortenzi, L, Petruzzi, C, Serio, A, Marcon, G, Sorbi, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 475
container_issue 6
container_start_page 472
container_title Biological psychiatry (1969)
container_volume 50
creator Nacmias, B
Tedde, A
Forleo, P
Piacentini, S
Guarnieri, B M
Bartoli, A
Ortenzi, L
Petruzzi, C
Serio, A
Marcon, G
Sorbi, S
description The aim of this study is to analyze the segregation of the 102T/C polymorphism in the serotonin 2A receptor gene in patients affected by sporadic and familial Alzheimer's disease (FAD) with and without psychotic symptoms. The polymorphism was analyzed in 275 subjects. A semistructured interview was used to obtain information about delusions, hallucinations, and other specific behavioral signs occurring during the disease. Fifty-two percent of AD patients with psychotic symptoms were homozygous for the C102 allele, as compared with 6.9% of AD patients without psychosis. Similarly, the C102/C102 genotype was significantly more frequent in FAD patients with psychosis than in FAD patients without (46.5% vs. 7.8%). Our data strongly confirm and extend to FAD previous studies suggesting that the genetic variation at this locus is associated with prominent psychotic features in AD and that the 102C allele could play an important role in late-onset AD.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71189342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71189342</sourcerecordid><originalsourceid>FETCH-LOGICAL-p546-71a82a38e90dc3496b56747bf64081d4b241b22dd9ae268c4fada12a919953ea3</originalsourceid><addsrcrecordid>eNo10M1LwzAYBvAcFDen_4Lk5Meh0Hw0bY5lqBMGXnavafKORZom5u2Q-tc7cJ4eHvjxHJ4LsizLUhWCc7Eg14ifp1pzzq7IgrFKKabUkny0iNF6M_k40h6mb4CRVsVm98jbJ5rBQppipikOc4g5HTwGakZHE872ECdvKc7hRAJSP9J2-DmAD5AfkDqPYBBuyOXeDAi351yR3cvzbr0ptu-vb-t2W6RKqqJmpuFGNKBLZ4XUqq9ULet-r2TZMCd7LlnPuXPaAFeNlXvjDONGM60rAUasyP3fbMrx6wg4dcGjhWEwI8QjdjVjjRaSn-DdGR77AK5L2QeT5-7_EvELalRcZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71189342</pqid></control><display><type>article</type><title>Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Nacmias, B ; Tedde, A ; Forleo, P ; Piacentini, S ; Guarnieri, B M ; Bartoli, A ; Ortenzi, L ; Petruzzi, C ; Serio, A ; Marcon, G ; Sorbi, S</creator><creatorcontrib>Nacmias, B ; Tedde, A ; Forleo, P ; Piacentini, S ; Guarnieri, B M ; Bartoli, A ; Ortenzi, L ; Petruzzi, C ; Serio, A ; Marcon, G ; Sorbi, S</creatorcontrib><description>The aim of this study is to analyze the segregation of the 102T/C polymorphism in the serotonin 2A receptor gene in patients affected by sporadic and familial Alzheimer's disease (FAD) with and without psychotic symptoms. The polymorphism was analyzed in 275 subjects. A semistructured interview was used to obtain information about delusions, hallucinations, and other specific behavioral signs occurring during the disease. Fifty-two percent of AD patients with psychotic symptoms were homozygous for the C102 allele, as compared with 6.9% of AD patients without psychosis. Similarly, the C102/C102 genotype was significantly more frequent in FAD patients with psychosis than in FAD patients without (46.5% vs. 7.8%). Our data strongly confirm and extend to FAD previous studies suggesting that the genetic variation at this locus is associated with prominent psychotic features in AD and that the 102C allele could play an important role in late-onset AD.</description><identifier>ISSN: 0006-3223</identifier><identifier>PMID: 11566166</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Alzheimer Disease - genetics ; Alzheimer Disease - psychology ; Apolipoproteins E - genetics ; Female ; Gene Amplification ; Gene Expression - genetics ; Gene Frequency ; Genotype ; Homozygote ; Humans ; Male ; Point Mutation - genetics ; Polymorphism, Genetic - genetics ; Psychotic Disorders - etiology ; Psychotic Disorders - genetics ; Psychotic Disorders - metabolism ; Receptors, Serotonin - genetics ; Receptors, Serotonin - metabolism</subject><ispartof>Biological psychiatry (1969), 2001-09, Vol.50 (6), p.472-475</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11566166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nacmias, B</creatorcontrib><creatorcontrib>Tedde, A</creatorcontrib><creatorcontrib>Forleo, P</creatorcontrib><creatorcontrib>Piacentini, S</creatorcontrib><creatorcontrib>Guarnieri, B M</creatorcontrib><creatorcontrib>Bartoli, A</creatorcontrib><creatorcontrib>Ortenzi, L</creatorcontrib><creatorcontrib>Petruzzi, C</creatorcontrib><creatorcontrib>Serio, A</creatorcontrib><creatorcontrib>Marcon, G</creatorcontrib><creatorcontrib>Sorbi, S</creatorcontrib><title>Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease</title><title>Biological psychiatry (1969)</title><addtitle>Biol Psychiatry</addtitle><description>The aim of this study is to analyze the segregation of the 102T/C polymorphism in the serotonin 2A receptor gene in patients affected by sporadic and familial Alzheimer's disease (FAD) with and without psychotic symptoms. The polymorphism was analyzed in 275 subjects. A semistructured interview was used to obtain information about delusions, hallucinations, and other specific behavioral signs occurring during the disease. Fifty-two percent of AD patients with psychotic symptoms were homozygous for the C102 allele, as compared with 6.9% of AD patients without psychosis. Similarly, the C102/C102 genotype was significantly more frequent in FAD patients with psychosis than in FAD patients without (46.5% vs. 7.8%). Our data strongly confirm and extend to FAD previous studies suggesting that the genetic variation at this locus is associated with prominent psychotic features in AD and that the 102C allele could play an important role in late-onset AD.</description><subject>Aged</subject><subject>Alzheimer Disease - genetics</subject><subject>Alzheimer Disease - psychology</subject><subject>Apolipoproteins E - genetics</subject><subject>Female</subject><subject>Gene Amplification</subject><subject>Gene Expression - genetics</subject><subject>Gene Frequency</subject><subject>Genotype</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Male</subject><subject>Point Mutation - genetics</subject><subject>Polymorphism, Genetic - genetics</subject><subject>Psychotic Disorders - etiology</subject><subject>Psychotic Disorders - genetics</subject><subject>Psychotic Disorders - metabolism</subject><subject>Receptors, Serotonin - genetics</subject><subject>Receptors, Serotonin - metabolism</subject><issn>0006-3223</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo10M1LwzAYBvAcFDen_4Lk5Meh0Hw0bY5lqBMGXnavafKORZom5u2Q-tc7cJ4eHvjxHJ4LsizLUhWCc7Eg14ifp1pzzq7IgrFKKabUkny0iNF6M_k40h6mb4CRVsVm98jbJ5rBQppipikOc4g5HTwGakZHE872ECdvKc7hRAJSP9J2-DmAD5AfkDqPYBBuyOXeDAi351yR3cvzbr0ptu-vb-t2W6RKqqJmpuFGNKBLZ4XUqq9ULet-r2TZMCd7LlnPuXPaAFeNlXvjDONGM60rAUasyP3fbMrx6wg4dcGjhWEwI8QjdjVjjRaSn-DdGR77AK5L2QeT5-7_EvELalRcZA</recordid><startdate>20010915</startdate><enddate>20010915</enddate><creator>Nacmias, B</creator><creator>Tedde, A</creator><creator>Forleo, P</creator><creator>Piacentini, S</creator><creator>Guarnieri, B M</creator><creator>Bartoli, A</creator><creator>Ortenzi, L</creator><creator>Petruzzi, C</creator><creator>Serio, A</creator><creator>Marcon, G</creator><creator>Sorbi, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20010915</creationdate><title>Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease</title><author>Nacmias, B ; Tedde, A ; Forleo, P ; Piacentini, S ; Guarnieri, B M ; Bartoli, A ; Ortenzi, L ; Petruzzi, C ; Serio, A ; Marcon, G ; Sorbi, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p546-71a82a38e90dc3496b56747bf64081d4b241b22dd9ae268c4fada12a919953ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aged</topic><topic>Alzheimer Disease - genetics</topic><topic>Alzheimer Disease - psychology</topic><topic>Apolipoproteins E - genetics</topic><topic>Female</topic><topic>Gene Amplification</topic><topic>Gene Expression - genetics</topic><topic>Gene Frequency</topic><topic>Genotype</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Male</topic><topic>Point Mutation - genetics</topic><topic>Polymorphism, Genetic - genetics</topic><topic>Psychotic Disorders - etiology</topic><topic>Psychotic Disorders - genetics</topic><topic>Psychotic Disorders - metabolism</topic><topic>Receptors, Serotonin - genetics</topic><topic>Receptors, Serotonin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nacmias, B</creatorcontrib><creatorcontrib>Tedde, A</creatorcontrib><creatorcontrib>Forleo, P</creatorcontrib><creatorcontrib>Piacentini, S</creatorcontrib><creatorcontrib>Guarnieri, B M</creatorcontrib><creatorcontrib>Bartoli, A</creatorcontrib><creatorcontrib>Ortenzi, L</creatorcontrib><creatorcontrib>Petruzzi, C</creatorcontrib><creatorcontrib>Serio, A</creatorcontrib><creatorcontrib>Marcon, G</creatorcontrib><creatorcontrib>Sorbi, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Biological psychiatry (1969)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nacmias, B</au><au>Tedde, A</au><au>Forleo, P</au><au>Piacentini, S</au><au>Guarnieri, B M</au><au>Bartoli, A</au><au>Ortenzi, L</au><au>Petruzzi, C</au><au>Serio, A</au><au>Marcon, G</au><au>Sorbi, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease</atitle><jtitle>Biological psychiatry (1969)</jtitle><addtitle>Biol Psychiatry</addtitle><date>2001-09-15</date><risdate>2001</risdate><volume>50</volume><issue>6</issue><spage>472</spage><epage>475</epage><pages>472-475</pages><issn>0006-3223</issn><abstract>The aim of this study is to analyze the segregation of the 102T/C polymorphism in the serotonin 2A receptor gene in patients affected by sporadic and familial Alzheimer's disease (FAD) with and without psychotic symptoms. The polymorphism was analyzed in 275 subjects. A semistructured interview was used to obtain information about delusions, hallucinations, and other specific behavioral signs occurring during the disease. Fifty-two percent of AD patients with psychotic symptoms were homozygous for the C102 allele, as compared with 6.9% of AD patients without psychosis. Similarly, the C102/C102 genotype was significantly more frequent in FAD patients with psychosis than in FAD patients without (46.5% vs. 7.8%). Our data strongly confirm and extend to FAD previous studies suggesting that the genetic variation at this locus is associated with prominent psychotic features in AD and that the 102C allele could play an important role in late-onset AD.</abstract><cop>United States</cop><pmid>11566166</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-3223
ispartof Biological psychiatry (1969), 2001-09, Vol.50 (6), p.472-475
issn 0006-3223
language eng
recordid cdi_proquest_miscellaneous_71189342
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Aged
Alzheimer Disease - genetics
Alzheimer Disease - psychology
Apolipoproteins E - genetics
Female
Gene Amplification
Gene Expression - genetics
Gene Frequency
Genotype
Homozygote
Humans
Male
Point Mutation - genetics
Polymorphism, Genetic - genetics
Psychotic Disorders - etiology
Psychotic Disorders - genetics
Psychotic Disorders - metabolism
Receptors, Serotonin - genetics
Receptors, Serotonin - metabolism
title Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A31%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%205-HT(2A)%20receptor%20polymorphism%20and%20psychotic%20symptoms%20in%20Alzheimer's%20disease&rft.jtitle=Biological%20psychiatry%20(1969)&rft.au=Nacmias,%20B&rft.date=2001-09-15&rft.volume=50&rft.issue=6&rft.spage=472&rft.epage=475&rft.pages=472-475&rft.issn=0006-3223&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71189342%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71189342&rft_id=info:pmid/11566166&rfr_iscdi=true